- Home
- SRPT vs ANDG Comparison
SRPT vs ANDG Comparison
Compare SRPT & ANDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | ANDG |
|---|---|---|
| Founded | 1980 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | ANDG |
|---|---|---|
| Price | $21.06 | $35.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 7 |
| Target Price | $25.85 | ★ $31.17 |
| AVG Volume (30 Days) | ★ 2.3M | 239.0K |
| Earning Date | 05-06-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | $16.02 |
| Revenue Next Year | N/A | $13.67 |
| P/E Ratio | ★ N/A | $44.38 |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $18.12 |
| 52 Week High | $64.80 | $36.54 |
Technical Indicators
Market Signals| Indicator | SRPT | ANDG |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 64.89 |
| Support Level | $20.61 | $26.01 |
| Resistance Level | $22.69 | N/A |
| Average True Range (ATR) | 0.90 | 2.05 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 65.94 | 91.67 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About ANDG Andersen Group Inc. Class A Common Stock
Andersen Group Inc is a provider of independent tax, valuation and financial advisory services to individuals and family offices, businesses and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services.